Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors

Abstract To present the feasibility of a dynamic whole-body (DWB) 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors (WD-NETs). Sixty-one patients who underwent a DWB 68Ga-DOTATOC-PET/CT for a histologically proven/highly suspected WD-NET were prospectively in...

Full description

Bibliographic Details
Main Authors: Philippe Thuillier, David Bourhis, Jean Philippe Metges, Romain Le Pennec, Karim Amrane, Ulrike Schick, Frédérique Blanc-Beguin, Simon Hennebicq, Pierre-Yves Salaun, Véronique Kerlan, Nicolas Karakatsanis, Ronan Abgral
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-83965-9
id doaj-d39da825f175412f822a6780af2476cf
record_format Article
spelling doaj-d39da825f175412f822a6780af2476cf2021-03-11T12:24:06ZengNature Publishing GroupScientific Reports2045-23222021-03-0111111510.1038/s41598-021-83965-9Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumorsPhilippe Thuillier0David Bourhis1Jean Philippe Metges2Romain Le Pennec3Karim Amrane4Ulrike Schick5Frédérique Blanc-Beguin6Simon Hennebicq7Pierre-Yves Salaun8Véronique Kerlan9Nicolas Karakatsanis10Ronan Abgral11Department of Endocrinology, University Hospital of BrestEA GETBO 3878, University Hospital of BrestDepartment of Oncology, University Hospital of BrestEA GETBO 3878, University Hospital of BrestDepartment of Radiotherapy, University Hospital of BrestDepartment of Radiotherapy, University Hospital of BrestEA GETBO 3878, University Hospital of BrestEA GETBO 3878, University Hospital of BrestEA GETBO 3878, University Hospital of BrestDepartment of Endocrinology, University Hospital of BrestDepartment of Radiology, Weil Cornell Medical College of Cornell UniversityEA GETBO 3878, University Hospital of BrestAbstract To present the feasibility of a dynamic whole-body (DWB) 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors (WD-NETs). Sixty-one patients who underwent a DWB 68Ga-DOTATOC-PET/CT for a histologically proven/highly suspected WD-NET were prospectively included. The acquisition consisted in single-bed dynamic acquisition centered on the heart, followed by the DWB and static acquisitions. For liver, spleen and tumor (1–5/patient), Ki values (in ml/min/100 ml) were calculated according to Patlak's analysis and tumor-to-liver (TLR-Ki) and tumor-to-spleen ratios (TSR-Ki) were recorded. Ki-based parameters were compared to static parameters (SUVmax/SUVmean, TLR/TSRmean, according to liver/spleen SUVmean), in the whole-cohort and according to the PET system (analog/digital). A correlation analysis between SUVmean/Ki was performed using linear and non-linear regressions. Ki-liver was not influenced by the PET system used, unlike SUVmax/SUVmean. The regression analysis showed a non-linear relation between Ki/SUVmean (R2 = 0.55,0.68 and 0.71 for liver, spleen and tumor uptake, respectively) and a linear relation between TLRmean/TLR-Ki (R2 = 0.75). These results were not affected by the PET system, on the contrary of the relation between TSRmean/TSR-Ki (R2 = 0.94 and 0.73 using linear and non-linear regressions in digital and analog systems, respectively). Our study is the first showing the feasibility of a DWB 68Ga-DOTATOC-PET/CT acquisition in WD-NETs.https://doi.org/10.1038/s41598-021-83965-9
collection DOAJ
language English
format Article
sources DOAJ
author Philippe Thuillier
David Bourhis
Jean Philippe Metges
Romain Le Pennec
Karim Amrane
Ulrike Schick
Frédérique Blanc-Beguin
Simon Hennebicq
Pierre-Yves Salaun
Véronique Kerlan
Nicolas Karakatsanis
Ronan Abgral
spellingShingle Philippe Thuillier
David Bourhis
Jean Philippe Metges
Romain Le Pennec
Karim Amrane
Ulrike Schick
Frédérique Blanc-Beguin
Simon Hennebicq
Pierre-Yves Salaun
Véronique Kerlan
Nicolas Karakatsanis
Ronan Abgral
Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
Scientific Reports
author_facet Philippe Thuillier
David Bourhis
Jean Philippe Metges
Romain Le Pennec
Karim Amrane
Ulrike Schick
Frédérique Blanc-Beguin
Simon Hennebicq
Pierre-Yves Salaun
Véronique Kerlan
Nicolas Karakatsanis
Ronan Abgral
author_sort Philippe Thuillier
title Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_short Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_full Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_fullStr Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_full_unstemmed Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
title_sort prospective study of dynamic whole-body 68ga-dotatoc-pet/ct acquisition in patients with well-differentiated neuroendocrine tumors
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-03-01
description Abstract To present the feasibility of a dynamic whole-body (DWB) 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors (WD-NETs). Sixty-one patients who underwent a DWB 68Ga-DOTATOC-PET/CT for a histologically proven/highly suspected WD-NET were prospectively included. The acquisition consisted in single-bed dynamic acquisition centered on the heart, followed by the DWB and static acquisitions. For liver, spleen and tumor (1–5/patient), Ki values (in ml/min/100 ml) were calculated according to Patlak's analysis and tumor-to-liver (TLR-Ki) and tumor-to-spleen ratios (TSR-Ki) were recorded. Ki-based parameters were compared to static parameters (SUVmax/SUVmean, TLR/TSRmean, according to liver/spleen SUVmean), in the whole-cohort and according to the PET system (analog/digital). A correlation analysis between SUVmean/Ki was performed using linear and non-linear regressions. Ki-liver was not influenced by the PET system used, unlike SUVmax/SUVmean. The regression analysis showed a non-linear relation between Ki/SUVmean (R2 = 0.55,0.68 and 0.71 for liver, spleen and tumor uptake, respectively) and a linear relation between TLRmean/TLR-Ki (R2 = 0.75). These results were not affected by the PET system, on the contrary of the relation between TSRmean/TSR-Ki (R2 = 0.94 and 0.73 using linear and non-linear regressions in digital and analog systems, respectively). Our study is the first showing the feasibility of a DWB 68Ga-DOTATOC-PET/CT acquisition in WD-NETs.
url https://doi.org/10.1038/s41598-021-83965-9
work_keys_str_mv AT philippethuillier prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT davidbourhis prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT jeanphilippemetges prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT romainlepennec prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT karimamrane prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT ulrikeschick prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT frederiqueblancbeguin prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT simonhennebicq prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT pierreyvessalaun prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT veroniquekerlan prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT nicolaskarakatsanis prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
AT ronanabgral prospectivestudyofdynamicwholebody68gadotatocpetctacquisitioninpatientswithwelldifferentiatedneuroendocrinetumors
_version_ 1724224297920102400